Wearables, Telehealth, Testing Platforms & Employers
Wearables built the most sophisticated biometric data set in history. Telehealth built new lines to clinical expertise. Testing platforms revealed the science of biomarkers. Each one hit a wall.
Data without a plan. Expertise that doesn't scale. Science without practical application.
LERA is the clinical action layer.
Built on 22 years of clinical experience and 20,000 women — turning symptoms, biomarkers, and user data into personalized whole-body guidance. Now you can plug in.
The market gap
Every platform in women's health is facing a build-versus-buy decision around the action layer. We've already built it.
Wearables
Built the most sophisticated biometric data set in history. But data without action is just a dashboard.
→ Ready for an action layer.
Telehealth
Built real clinical expertise. But a model dependent on 1:1 visits doesn't scale.
→ Ready for a scale layer.
Testing platforms
Made biomarkers visible in ways not possible five years ago. But visibility without a plan leaves women stuck.
→ Ready for a plan layer.
The problem at scale
Fragmentation isn't just inefficient — it's expensive. For women, employers, and the platforms trying to serve them.
17%
average utilization across fragmented women's health offerings
SHRM 2025
$150B
in lost productivity tied to women's unaddressed health conditions
McKinsey 2024
87%
of employers say measuring ROI on health benefits is a top challenge
McKinsey 2025
LERA works
In digital health, that almost never happens. Women reported feeling better — and their biomarkers agreed. That's not engagement data. That's a clinical outcome.
94%
Member retention
Paying members over 6 months. Industry median: 48%.
72
Net Promoter Score
Healthcare average: 38. Score of 70+ = world class.
Symptom reduction
% of women reporting improvement
78%
Stress, resilience & sleep
75%
Hormones, cycle & mood
78%
Gut, digestion & comfort
78%
Metabolic, diet & movement
Biomarker improvement
% of women with measurable change
71%
Inflammation markers reduced
100%
Nutrient deficiencies corrected
89%
Members lost weight
74%
Food sensitivities resolved
Source: White Paper Report, LERA Health's Lifestyle Medicine Intervention Validated in Cohort Study
How we work together
Three paths to partnership. One destination — LERA embedded inside the women's health ecosystem.
LERA turns your platform's signals into clinical context, personalized guidance, and real health changes. That's what keeps members engaged — and subscribed — long term.
Solve churn at the root. Members leave when data doesn't translate to action. LERA closes the loop between insight and outcome — eliminating the "so what?" that drives drop-off.
Increase LTV. Longitudinal, whole-body care creates lasting engagement. Members who see results — in their symptoms and their biomarkers — stay.
Add clinical credibility. LERA's biomarker + behavior + coaching layer adds clinical weight to your platform — differentiating you in a crowded market.
White-label ready. LERA is built, clinically and technically, to integrate inside wearable, telehealth, and testing platforms.
“For decades, women have been handed pieces of the puzzle — a lab result, a diagnosis, a one-size-fits-all recommendation — but never the full picture. Never a system that sees it all together and actually tells them what to do. That's the void LERA fills.”
— Jennifer Voss, Co-Founder & CEO, LERA Health
We're selectively building partnerships with platforms and employers who share our conviction that women's health is a systems problem — and that solving it changes everything.
If that's you, let's talk.